Friday - October 16, 2026
Goodwin Advises OMass Therapeutics on $310 Million Series C
October 15, 2026
BOSTON, Massachusetts, Oct. 15 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises OMass Therapeutics on $310 Million Series C

*

The Life Sciences team advised OMass Therapeutics on an oversubscribed $310 million Series C financing to advance its portfolio of small-molecule therapeutics in endocrinology and immunology. The round was co-led by new investors Bain Capital Life Sciences, Forbion . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products